BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.
Clinical trial NCT06773312 · RECRUITING
Trial details
- NCT number
- NCT06773312
- Sponsor
- Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2026-10-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.